Literature DB >> 10655416

Comparative evaluation of two branched-DNA human immunodeficiency virus type 1 RNA quantification assays with lower detection limits of 50 and 500 copies per milliliter.

C Manegold1, C Krempe, H Jablonowski, L Kajala, M Dietrich, O Adams.   

Abstract

We have comparatively evaluated Quantiplex version 3.0 and version 2. 0 on 133 plasma samples and a repetitive dilution series. Version 3. 0 yielded higher human immunodeficiency virus RNA values, and the ratio of version 3.0 results to version 2.0 results decreased from 3. 47 below 1,000 copies/ml to 1.97 above 50,000 copies/ml [linear regression, log (version 3.0) = 0.915 + 0.871 x log (version 2.0); r(2) = 0.952].

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10655416      PMCID： PMC86246     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV monitor test.

Authors:  A M Vandamme; J C Schmit; S Van Dooren; K Van Laethem; E Gobbers; W Kok; P Goubau; M Witvrouw; W Peetermans; E De Clercq; J Desmyter
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-10-01

2.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

3.  Variance of plasma human immunodeficiency virus type 1 RNA levels measured by branched DNA within and between days.

Authors:  S G Deeks; R L Coleman; R White; C Pachl; M Schambelan; D N Chernoff; M B Feinberg
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

4.  The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir.

Authors:  D J Kempf; R A Rode; Y Xu; E Sun; M E Heath-Chiozzi; J Valdes; A J Japour; S Danner; C Boucher; A Molla; J M Leonard
Journal:  AIDS       Date:  1998-03-26       Impact factor: 4.177

5.  Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma.

Authors:  F S Nolte; J Boysza; C Thurmond; W S Clark; J L Lennox
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

6.  Intra-assay performance characteristics of five assays for quantification of human immunodeficiency virus type 1 RNA in plasma.

Authors:  H J Lin; L Pedneault; F B Hollinger
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

7.  An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma.

Authors:  D Kern; M Collins; T Fultz; J Detmer; S Hamren; J J Peterkin; P Sheridan; M Urdea; R White; T Yeghiazarian; J Todd
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

8.  Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma.

Authors:  J Coste; B Montes; J Reynes; M Peeters; C Segarra; J P Vendrell; E Delaporte; M Segondy
Journal:  J Med Virol       Date:  1996-12       Impact factor: 2.327

9.  Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy.

Authors:  J M Raboud; J S Montaner; B Conway; S Rae; P Reiss; S Vella; D Cooper; J Lange; M Harris; M A Wainberg; P Robinson; M Myers; D Hall
Journal:  AIDS       Date:  1998-09-10       Impact factor: 4.177

10.  Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.

Authors:  J W Mellors; C R Rinaldo; P Gupta; R M White; J A Todd; L A Kingsley
Journal:  Science       Date:  1996-05-24       Impact factor: 47.728
View more
  3 in total

1.  Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA version 3.0.

Authors:  P Swanson; V Soriano; S G Devare; J Hackett
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

2.  Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma.

Authors:  D G Murphy; L Côté; M Fauvel; P René; J Vincelette
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

3.  Intrapatient diversity and its correlation with viral setpoint in human immunodeficiency virus type 1 CRF02_A/G-IbNG infection.

Authors:  Indu Mani; Peter Gilbert; Jean-Louis Sankalé; Geoffrey Eisen; Souleymane Mboup; Phyllis J Kanki
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.